日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Chitinase-3-like Protein 1 (YKL-40): A New Biomarker of Inflammation in Pyoderma Gangrenosum

几丁质酶-3 样蛋白 1 (YKL-40):坏疽性脓皮病炎症的新生物标志物

Alina Jankowska-Konsur, Magdalena Łyko, Klaudia Rubas, Danuta Nowicka-Suszko, Joanna Maj, Jacek C Szepietowski

Increased Serum Levels of S100A4 and S100A15 in Individuals Suffering from Hidradenitis Suppurativa

化脓性汗腺炎患者血清中 S100A4 和 S100A15 水平升高

Aleksandra Batycka-Baran, Łukasz Matusiak, Danuta Nowicka-Suszko, Jacek C Szepietowski, Wojciech Baran

Soluble Receptor for Advanced Glycation End Products: A Novel Biomarker for Psoriasis Severity with Therapeutic Implications?

晚期糖基化终产物可溶性受体:一种具有治疗意义的银屑病严重程度的新型生物标志物?

Aleksandra Batycka-Baran, Wojciech Baran, Danuta Nowicka-Suszko, Jacek C Szepietowski

Chitinase-3-like protein 1 (YKL-40) is a biomarker of severity of joint involvement in psoriatic arthritis

几丁质酶-3 样蛋白 1 (YKL-40) 是银屑病关节炎关节病变严重程度的生物标志物

Joanna Salomon, Łukasz Matusiak, Danuta Nowicka-Suszko, Jacek C Szepietowski

Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents

化脓性汗腺炎患者血清白细胞介素 (IL)-17 水平升高:对使用抗 IL-17 药物治疗的启示

Łukasz Matusiak, Justyna Szczęch, Andrzej Bieniek, Danuta Nowicka-Suszko, Jacek C Szepietowski

Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis

几丁质酶-3 样蛋白 1 (YKL-40) 是银屑病炎症的新生物标志物

Joanna Salomon, Łukasz Matusiak, Danuta Nowicka-Suszko, Jacek C Szepietowski

Chitinase-3-Like Protein 1 (YKL-40) Reflects the Severity of Symptoms in Atopic Dermatitis

几丁质酶-3 样蛋白 1 (YKL-40) 反映特应性皮炎症状的严重程度

Joanna Salomon, Łukasz Matusiak, Danuta Nowicka-Suszko, Jacek C Szepietowski